We are live on
!
Find out more
Boston Trust Walden Portfolio holdings
AUM
$13.1B
Turnover
6.42%
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter
Est. Return
-0.51%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.56B
AUM Growth
-$179M
(-2.7%)
Cap. Flow
-$104M
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
11.86%
Holding
354
New
15
Increased
110
Reduced
195
Closed
8
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Masimo
MASI
|
+$26.8M |
| 2 |
Big Lots, Inc.
BIG
|
+$24.1M |
| 3 |
Horace Mann Educators
HMN
|
+$20.2M |
| 4 |
Dollar General
DG
|
+$19.9M |
| 5 |
DHI Group
DHX
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackbaud
BLKB
|
+$30.3M |
| 2 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$24.5M |
| 3 |
MarketAxess Holdings
MKTX
|
+$23.7M |
| 4 |
Commercial Metals
CMC
|
+$19.5M |
| 5 |
ICU Medical
ICUI
|
+$18.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.07% |
| 2 | Technology | 16.27% |
| 3 | Healthcare | 15.05% |
| 4 | Industrials | 12.85% |
| 5 | Consumer Discretionary | 11.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Core Laboratories
CLB
$459M
| $8.08M | 0.12% |
70,823
-8,880
| -11% | -$1.08M |
2013 Q2
8 quarters
|
|
202
Pediatrix Medical
MD
$2.22B
| $7.67M | 0.12% |
103,428
+3,597
| +4% | +$259K |
2013 Q2
8 quarters
|
|
203
Edwards Lifesciences
EW
$49.9B
| $7.4M | 0.11% |
311,700
| – | – |
2013 Q2
8 quarters
|
|
204
Lakeland Financial Corp
LKFN
$1.44B
| $7.24M | 0.11% |
+250,508
| New | +$6.79M |
2015 Q2
0 quarters
|
|
205
Service Corp International
SCI
$11.1B
| $7.12M | 0.11% |
241,884
-282,910
| -54% | -$8.02M |
2013 Q4
6 quarters
|
|
|
SIVB
206
DELISTED
SVB Financial Group
SIVB
| $7.09M | 0.11% |
49,220
-1,152
| -2% | -$156K |
2013 Q2
8 quarters
|
|
207
Digital Realty Trust
DLR
$65.3B
| $6.85M | 0.1% |
102,776
+2,660
| +3% | +$175K |
2013 Q2
8 quarters
|
|
208
CorVel
CRVL
$4.03B
| $6.82M | 0.1% |
638,805
-3,978
| -0.6% | -$46.3K |
2013 Q4
6 quarters
|
|
209
Middleby
MIDD
$4.87B
| $6.58M | 0.1% |
58,581
-1,123
| -2% | -$120K |
2013 Q2
8 quarters
|
|
210
F5
FFIV
$25B
| $6.57M | 0.1% |
54,623
+5,139
| +10% | +$632K |
2013 Q2
8 quarters
|
|
211
Check Point Software Technologies
CHKP
$14.1B
| $6.51M | 0.1% |
81,870
+4,699
| +6% | +$397K |
2013 Q2
8 quarters
|
|
212
Intel
INTC
$475B
| $6.48M | 0.1% |
213,189
-12,223
| -5% | -$395K |
2013 Q2
8 quarters
|
|
213
IBM
IBM
$219B
| $6.34M | 0.1% |
40,800
-2,707
| -6% | -$435K |
2013 Q2
8 quarters
|
|
214
DELISTED
Atrion Corp
ATRI
| $6.1M | 0.09% |
+15,543
| New | +$5.55M |
2015 Q2
0 quarters
|
|
215
Williams-Sonoma
WSM
$29.5B
| $5.79M | 0.09% |
140,848
+4,366
| +3% | +$171K |
2013 Q4
6 quarters
|
|
216
Teradata
TDC
$2.82B
| $5.7M | 0.09% |
154,061
+1,715
| +1% | +$70.6K |
2013 Q2
8 quarters
|
|
|
ABB
217
DELISTED
ABB Ltd
ABB
| $5.62M | 0.09% |
269,060
-124,650
| -32% | -$2.74M |
2013 Q2
8 quarters
|
|
218
Centene
CNC
$34.2B
| $5.44M | 0.08% |
135,364
-2,084
| -2% | -$74.8K |
2014 Q2
4 quarters
|
|
219
IDEX
IEX
$17.4B
| $5.42M | 0.08% |
68,980
+3,689
| +6% | +$286K |
2013 Q2
8 quarters
|
|
220
TJX Companies
TJX
$162B
| $5.4M | 0.08% |
163,178
+514
| +0.3% | +$17.1K |
2013 Q2
8 quarters
|
|
221
Phillips 66
PSX
$117B
| $5.05M | 0.08% |
62,675
-17
| -0% | -$1.35K |
2013 Q2
8 quarters
|
|
|
GAS
222
DELISTED
AGL Resources Inc
GAS
| $4.81M | 0.07% |
103,264
+2,186
| +2% | +$108K |
2013 Q2
8 quarters
|
|
223
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $4.72M | 0.07% |
59,368
-2,200
| -4% | -$176K |
2013 Q2
8 quarters
|
|
224
Johnson Controls International
JCI
$88.1B
| $4.52M | 0.07% |
87,139
-5,252
| -6% | -$281K |
2013 Q2
8 quarters
|
|
225
GE Aerospace
GE
$326B
| $4.37M | 0.07% |
34,302
-300
| -0.9% | -$38.9K |
2013 Q2
8 quarters
|
|
Similar funds
Boston Trust Walden's Q2 2015 Portfolio in Review
As of Q2 2015, Boston Trust Walden held 354 positions worth $6.56B, down 2.7% from $6.74B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Boston Trust Walden's Q2 2015 filing shows 15 new, 110 increased, 195 reduced and 8 closed positions. Its largest new stake was Masimo: 749,049 shares worth $29M. The largest sale was Blackbaud, an estimated $30.3M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- Boston Trust Walden's largest Q2 2015 buy was Masimo: 749,049 shares worth $29M.
- Boston Trust Walden added most to Merck in Q2 2015, an estimated $16.8M increase.
- Boston Trust Walden's biggest Q2 2015 reduction was Mellanox Technologies, Ltd., cutting an estimated $24.5M.
- Boston Trust Walden fully exited Blackbaud in Q2 2015, selling an estimated $30.3M.
- Boston Trust Walden's ten largest holdings make up 12% of its $6.56B portfolio in Q2 2015.
- Boston Trust Walden opened 15 new positions and closed 8 in Q2 2015.
- Boston Trust Walden's portfolio value fell 2.7% quarter-over-quarter to $6.56B.
Based on Boston Trust Walden's 13F filing for Q2 2015, filed 17 Jul 2015.